Mitzi Nagarkatti to Tumor Cells, Cultured
This is a "connection" page, showing publications Mitzi Nagarkatti has written about Tumor Cells, Cultured.
Connection Strength
0.160
-
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Blood. 2002 Jul 15; 100(2):627-34.
Score: 0.044
-
Evidence for the participation of interleukin-2 (IL-2) and IL-4 in the regulation of autonomous growth and tumorigenesis of transformed cells of lymphoid origin. Blood. 1997 Jan 15; 89(2):610-20.
Score: 0.030
-
Role of IL-2, IL-4 and IL-6 in the growth and differentiation of tumor-specific CD4+ T helper and CD8+ T cytotoxic cells. Int J Cancer. 1990 Jun 15; 45(6):1096-104.
Score: 0.019
-
Calcium ionophores at concentrations mitogenic to normal murine T cells inhibit the proliferation of tumor cells in vitro. Cancer Commun. 1989; 1(5):329-34.
Score: 0.017
-
Delta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria. Mol Cancer Res. 2006 Aug; 4(8):549-62.
Score: 0.015
-
Growth of FasL-bearing tumor cells in syngeneic murine host induces apoptosis and toxicity in Fas(+) organs. Blood. 2000 Mar 15; 95(6):2111-7.
Score: 0.009
-
Evidence for the involvement of CD44 in endothelial cell injury and induction of vascular leak syndrome by IL-2. J Immunol. 1999 Aug 01; 163(3):1619-27.
Score: 0.009
-
Evidence for the involvement of Fas ligand and perforin in the induction of vascular leak syndrome. J Immunol. 1998 Sep 15; 161(6):3077-86.
Score: 0.008
-
Fas-Fas ligand-based interactions between tumor cells and tumor-specific cytotoxic T lymphocytes: a lethal two-way street. Blood. 1997 Sep 01; 90(5):1952-9.
Score: 0.008